ICD 10 CM C43.30 | Description & Clinical Information

ICD 10 C43.30 describes a type of cancer known as malignant melanoma, which is characterized by the abnormal growth and multiplication of cells responsible for producing melanin, the pigment that gives color to skin, hair, and eyes, and if left untreated, can spread to the surrounding tissues; in this particular case, the provider has documented that the patient has malignant melanoma of the face, but has not specified which part.

Official Description Of C43.30

The ICD 10 CM book defines ICD 10 code C43.30 as:

Malignant melanoma of unspecified part of face
Parent Code Notes: C43

Excludes1: melanoma in situ (D03.-)

Excludes2: malignant melanoma of skin of genital organs (C51-C52, C60.-, C63.-)
Merkel cell carcinoma (C4A.-)
sites other than skin-code to malignant neoplasm of the site

When To Use C43.30

The diagnosis describes by ICD-10-CM C43.30 refers to a patient with malignant melanoma, a type of skin cancer that can occur on any part of the body, including the face, neck, arms, or legs. However, when it affects the face, it can present as an atypical maculopapular lesion. This type of cancer can progress rapidly and may pose a significant risk to the patient’s life if it is not caught early.

Symptoms of malignant melanoma of the face may start as a small lesion that can be itchy, painful or have an abnormal growth pattern. As the lesion grows, it may change color and have irregular borders with varying diameters, making it difficult for the patient or the doctor to identify precisely. In advanced stages, the lesion may become ulcerated, which can indicate that the cancer has spread to surrounding tissues.

To diagnose malignant melanoma, the physician will examine the patient and obtain a full medical history. They may also order a series of laboratory tests, including a complete blood cell count, serum chemistry test, alanine transaminase (AST), aspartate transaminase (ALT), lactate dehydrogenase level, and a microscopic examination of biopsy specimens. Furthermore, the doctor can use imaging studies such as computed tomography (CT) and positron emission tomography (PET) to help them diagnose and stage the cancer.

Treatment for malignant melanoma of the face will ultimately depend on the stage and severity of the cancer. Surgical procedures, such as excision and lymph node dissection, are commonly used. Chemotherapy may also be recommended to destroy cancer cells and prevent the spread of the disease. The physician will base the treatment plan on the patient’s individual circumstances, including their age, health status, and personal preferences.

The risk factors for developing malignant melanoma include repeated or severe sunburns and extended exposure to UV radiation. People with certain genetic factors and immune-compromised individuals are also at a high risk of developing this dangerous form of skin cancer. It is vital to maintain regular skin check-ups and to protect yourself from harmful UV rays by wearing protective clothing and sunscreen.

Although malignant melanoma is not common, accounting for less than 2% of all cancers in the United States, it is the leading cause of skin cancer-related deaths. Therefore, early detection and prompt treatment are crucial in ensuring a successful outcome for the patient.

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *